Ambiq vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Ambiq

ChallengerArtificial Intelligence

Ultra-Low-Power AI Chips for Wearables

Raised significant Series C funding. Apollo SoC processes AI at 10x lower energy than competing chips. Powers AI features in smart wearables, hearables, and IoT devices. Licensing and chip sales model.

About

Ambiq is a semiconductor company developing ultra-low-power system-on-chip (SoC) solutions that enable AI computation directly on wearable devices, hearing aids, earbuds, and IoT sensors — without draining batteries or requiring cloud connectivity. The company's Apollo SoC family processes AI inference at approximately 10x lower energy than competing chips designed for mobile or edge applications, enabling health monitoring AI, voice recognition, and personalization algorithms to run continuously on battery-powered devices.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.